Jon N. Marsh

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth

Soman, Neelesh R., Baldwin, Steven L., Hu, Grace, Marsh, Jon N., Lanza, Gregory M., Heuser, John E., ...

The in vivo application of cytolytic peptides for cancer therapeutics is hampered by toxicity, nonspecificity, and degradation. We previously developed a specific strategy to synthesize a nanoscale...